AIkido Pharma Inc.: Invitation to the Q2 Virtual Investor Summit – StreetInsider.com

0
27

AIkido Pharma Inc.: Invitation to the Q2 Virtual Investor Summit





<!–

var siteInfo = new Array(12, ‘www.streetinsider.com’, ‘ic_landing.html’);
IC.LoadView(siteInfo);

–>

<!–

–>

Get it on Google Play

May 13, 2021 9:03 AM EDT


News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.


New York, New York–(Newsfile Corp. – May 13, 2021) – AIkido Pharma Inc. (NASDAQ: AIKI) today announced that Darrell G. Dotson, Vice President and General Counsel will be attending the Q2 Virtual Investor Summit.

About AIkido Pharma Inc.

AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology Company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company’s platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and University of Maryland at Baltimore . Our diverse pipeline of therapeutics includes therapies for pancreatic cancer and prostate cancer. We are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.

Forward-Looking Statements

Certain statements in this press release constitute forward-looking statements within the meaning of the federal securities laws. Words such as may, might, will, should, believe, expect, anticipate, estimate, continue, predict, forecast, project, plan, intend or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company’s filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:

Hayden IR
Brett Maas, Managing Partner
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com

AIkido Pharma Inc.:

Phone: 212-745-1373
Email: investorrelations@aikidopharma.com
www.aikidopharma.com

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website atwww.investorsummitgroup.com

Contact:

Sasha Murray at sasha@investorsummitgroup.com


Serious News for Serious Traders! Try StreetInsider.com Premium Free!


You May Also Be Interested In


Quantcast

LEAVE A REPLY

Please enter your comment!
Please enter your name here